A detailed history of Federated Hermes, Inc. transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 66,019 shares of A stock, worth $8.39 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
66,019
Previous 106,908 38.25%
Holding current value
$8.39 Million
Previous $13.9 Million 29.27%
% of portfolio
0.02%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$125.42 - $148.48 $5.13 Million - $6.07 Million
-40,889 Reduced 38.25%
66,019 $9.8 Million
Q2 2024

Aug 08, 2024

BUY
$129.63 - $154.64 $853,354 - $1.02 Million
6,583 Added 6.56%
106,908 $13.9 Million
Q1 2024

May 14, 2024

SELL
$128.12 - $149.31 $406,012 - $473,163
-3,169 Reduced 3.06%
100,325 $14.6 Million
Q4 2023

Jan 31, 2024

SELL
$101.17 - $139.82 $26.9 Million - $37.1 Million
-265,576 Reduced 71.96%
103,494 $14.4 Million
Q3 2023

Nov 13, 2023

SELL
$109.73 - $128.47 $8.12 Million - $9.51 Million
-74,027 Reduced 16.71%
369,070 $41.3 Million
Q2 2023

Aug 14, 2023

BUY
$114.69 - $141.28 $3.74 Million - $4.6 Million
32,590 Added 7.94%
443,097 $53.3 Million
Q1 2023

May 08, 2023

BUY
$131.13 - $159.06 $19.2 Million - $23.3 Million
146,192 Added 55.31%
410,507 $56.8 Million
Q4 2022

Feb 13, 2023

SELL
$125.64 - $157.68 $3.81 Million - $4.78 Million
-30,290 Reduced 10.28%
264,315 $39.6 Million
Q3 2022

Nov 14, 2022

SELL
$115.11 - $142.29 $7.93 Million - $9.8 Million
-68,883 Reduced 18.95%
294,605 $35.8 Million
Q2 2022

Aug 15, 2022

SELL
$112.71 - $135.93 $8.49 Million - $10.2 Million
-75,350 Reduced 17.17%
363,488 $43.2 Million
Q1 2022

May 13, 2022

BUY
$126.0 - $156.48 $16.1 Million - $20 Million
127,586 Added 40.99%
438,838 $58.1 Million
Q4 2021

Feb 14, 2022

BUY
$147.95 - $164.3 $4.82 Million - $5.36 Million
32,594 Added 11.7%
311,252 $49.7 Million
Q3 2021

Nov 15, 2021

BUY
$147.58 - $179.28 $12.6 Million - $15.4 Million
85,641 Added 44.37%
278,658 $43.9 Million
Q2 2021

Aug 16, 2021

SELL
$127.69 - $148.81 $3.06 Million - $3.57 Million
-23,991 Reduced 11.06%
193,017 $28.5 Million
Q1 2021

May 13, 2021

BUY
$114.99 - $130.12 $4.76 Million - $5.38 Million
41,365 Added 23.55%
217,008 $27.6 Million
Q4 2020

Feb 12, 2021

BUY
$100.01 - $119.3 $1.82 Million - $2.17 Million
18,219 Added 11.57%
175,643 $20.8 Million
Q3 2020

Nov 12, 2020

BUY
$88.11 - $103.42 $744,000 - $873,278
8,444 Added 5.67%
157,424 $15.9 Million
Q2 2020

Aug 13, 2020

BUY
$68.92 - $91.14 $984,315 - $1.3 Million
14,282 Added 10.6%
148,980 $13.2 Million
Q1 2020

May 13, 2020

SELL
$63.37 - $90.13 $1.77 Million - $2.52 Million
-27,960 Reduced 17.19%
134,698 $9.65 Million
Q4 2019

Feb 14, 2020

SELL
$72.49 - $85.45 $5.99 Million - $7.06 Million
-82,569 Reduced 33.67%
162,658 $13.9 Million
Q3 2019

Nov 14, 2019

SELL
$65.59 - $78.07 $1.89 Million - $2.25 Million
-28,788 Reduced 10.51%
245,227 $18.8 Million
Q2 2019

Aug 14, 2019

SELL
$66.89 - $81.94 $9.45 Million - $11.6 Million
-141,265 Reduced 34.02%
274,015 $20.5 Million
Q1 2019

May 10, 2019

BUY
$63.27 - $82.0 $1.51 Million - $1.95 Million
23,811 Added 6.08%
415,280 $33.4 Million
Q4 2018

Feb 13, 2019

SELL
$61.13 - $74.67 $4.43 Million - $5.41 Million
-72,461 Reduced 15.62%
391,469 $26.4 Million
Q3 2018

Nov 13, 2018

BUY
$61.25 - $71.13 $7.03 Million - $8.16 Million
114,733 Added 32.86%
463,930 $32.7 Million
Q2 2018

Aug 10, 2018

BUY
$61.14 - $69.55 $2.25 Million - $2.56 Million
36,767 Added 11.77%
349,197 $21.6 Million
Q1 2018

May 09, 2018

SELL
$65.05 - $74.82 $13,595 - $15,637
-209 Reduced 0.07%
312,430 $20.9 Million
Q4 2017

Feb 14, 2018

SELL
$64.87 - $70.59 $43,657 - $47,507
-673 Reduced 0.21%
312,639 $0
Q3 2017

Nov 13, 2017

BUY
$58.57 - $66.17 $18.4 Million - $20.7 Million
313,312
313,312 $20.1 Million

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $37.6B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.